news > company > article

isoSolutions Marketing & Management Inc. and CNIC partner to promote nuclear medicine applications

Patricia ActonPosted by Patricia Acton ⎜ Feb 11, 2020 ⎜ Company

TORONTO – February 11, 2020 isoSolutions Marketing & Management Inc. (isoSolutions), an innovative one stop shop when it comes to nuclear medicine products has joined a growing list of organizations as members of the Canadian Nuclear Isotope Council (CNIC) an independent body made up of representatives from the Canadian health sector, nuclear industry and leading research groups, convened to promote Canada’s role in the production of the world’s supply of radioisotopes.


Medical isotopes are very important, particularly for diagnostic purposes in oncology; cardiology and neurology. Canada has been a pioneer in the development of radioisotopes, saving millions of lives in more than 80 countries for over six decades. We have demonstrated world-class nuclear expertise and achievements, leading to significant advancements in medical imaging, cancer therapy, sterilization, food and water safety, and disease prevention.


“A secure supply of a diverse portfolio of isotopes is essential to maintaining and improving our standard of living. Isotopes are used every day to verify the safety of our roadways, discover and develop natural resources, test industrial products, and support research in mental health and aging,” said James Scongack- Chair of the CNIC. People suffering from these horrible illnesses are counting on Canada. Now more than ever it’s time for Canada to lead. When it comes to meeting some of the world’s greatest health challenges, all eyes are on Canada. We need to step up and provide the leadership in this area the world has always counted on Canada for.


“People and patients matter the most. Every organization should aim to leave people better off. In the health sector that starts with the patient but must also include our suppliers, customers, employees, partners — indeed, everyone whose life is touched by isotopes in some way,” said David Drummond, Managing Director of isoSolutions. “If Canada is to maintain its standing as a leading force in global science — and enjoy the associated economic and societal benefits — partnerships like this one with the CNIC will help us get there.”


A report released by the CNIC in September highlighted the need for strong Canadian leadership to ensure a domestic and international supply of medical isotopes. This presents a major challenge – and opportunity – for Canadian leadership in the training, research, development, deployment and export of medical isotopes for the global market. The report makes it clear that Canada must enable investment in its isotope infrastructure and ensure the building blocks are in place for this sector to remain a global leader. Such investments would exhibit a commitment to Canada’s role as a leader in nuclear medicine, and dramatically bolster the country’s capacity to innovate while delivering substantial economic and societal benefits to both Canadians and patients around the globe.

Added Scongack, “I believe the Canadian Nuclear Isotope Council (CNIC) has grown to over 55 respected members from across the Country in 2019 will play a role working alongside these organizations and both Provincial and Federal levels of Government and also expand the partners in this mission.”

This year the CNIC will continue to promote public awareness about the use and benefits of medical/industrial isotopes and radiation technologies, and work with government stakeholders to ensure that the public policy landscape promotes innovation and supports the increased proliferation of medical and industrial isotope uses.

About The Canadian Nuclear Isotope Council

The CNIC is a coalition of science, health care and nuclear sector organizations to ensure Canada remains a world leader in the production of life-saving isotopes by bringing awareness and supporting long-term policies at the domestic and international level that will save countless lives and support health-care innovation for decades to come. To learn more about the CNIC visit www.CanadianIsotopes.ca and follow us on, Facebook, Twitter, and LinkedIn.

For more information, please contact:
Andrew Thiele
Strategist, Government and Stakeholder Relations – Corporate Affairs
Canadian Nuclear Isotope Council
226.930.1869
canadianisotopes@gmail.com

About isoSolutions Marketing & Management Inc.


isoSolutions provides a one-stop shopping service as well as technical support worldwide for nuclear medicine applications including: Radiochemicals, Stable isotopes, Labeled compounds, Sealed sources, Synthesizers and Peptides. We provide a complete range of Radioisotopes, including a Ga-68 Generator, Lu-177, Y-90, a Re-188 Generator, I-131, I-125 and cyclotron products.


These products are complemented by an automated labeling module for development work or preprogrammed syntheses and a complete line of quality control instruments. We also offer consulting services for radiochemistry, grant applications and licensing (CMC sections, INDs, DMFs) in several regions of the globe. For more information, please contact:


Pat Acton
Sales Manager, Canada
pacton@isosolutions.com
+1(250) 889-5602
www.isoSolutions.com